Delivery Order SPE2DB22D3401-SPE2DB25FT6AL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,021.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mirtazapine 7.5 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order operates under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,216.91 and an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,402.57 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Mirtazapine 15 mg, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty-four thousand seven hundred dollars and seventy cents ($144,700) to Amerisourcebergen Drug Corporation for the supply of one thousand (1,000) packages of fifteen (15) milligram Mirtazapine tablets. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 31, 2023 to fulfill requirements under the Agency's pharmaceutical supply vehicle. As a top provider...
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to Amerisourcebergen Drug Corporation for 30-count packages of 7.5 mg Mirtazapine tablets. Valued at $310.86, this firm fixed price order calls for delivery to a facility in Conshohocken, Pennsylvania between August 4-7, 2023. As a major provider of pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this requirement for the antidepressant medication in support of DLA's mission to...
- The Defense Logistics Agency Troop Support Medical awarded a $507.30 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 500 units of 30mg Mirtazapine. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products to the place of performance in Conshohocken, Pennsylvania by August 25, 2023. The Defense Logistics Agency supports Department of Defense readiness by procuring and providing medical supplies under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,402.15 firm fixed-price delivery order is for the supply of 4558748574 - Mirtazapine 7.5 mg tablets in 30-count packages. The contract has an ultimate completion date of October 13, 2022 and was awarded on October 12, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- Defense Logistics Agency awarded a firm fixed price delivery order against an unidentified contract vehicle to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply one hundred tablets of 15mg Mirtazapine for $53. Performance will occur in Conshohocken, Pennsylvania by October 13, 2023. The order was placed on October 12, 2023 and contains no set aside designation. As a major provider of pharmaceuticals to the DLA, this order for antidepressant medication supports...
- The Defense Logistics Agency awarded a $1,574.56 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 15 mg Mirtazapine. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 12, 2023 in support of the Defense Logistics Agency's pharmaceutical procurement programs. No subcontractors or set aside designations were identified. The delivery order was issued under an existing DLA pharmaceutical supply vehicle to...
- The Defense Logistics Agency awarded a $133,550 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 bottles of 45mg Mirtazapine tablets. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 31, 2023 in support of the Defense Logistics Agency's medical supply needs. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested Mirtazapine tablets to the Defense Logistics Agency...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6ALDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 500 units, valued at $5,732.50 under a firm fixed-price contract. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under its existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. This contract supports the Defense Logistics Agency's medical supply chain operations serving military healthcare systems and federal medical procurement needs. Mirtazapine is an antidepressant medication commonly used in military and veterans' healthcare settings for mood disorders. AmerisourceBergen Drug Corp's extensive portfolio with DLA encompasses a broad range of pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's performance under this delivery order contributes to the broader Pharmaceutical Prime Vendor Global Program, which strategically distributes pharmaceutical procurement across multiple regional contracts to ensure reliable medical supply availability to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 9/8/25 |